Abstract
e12507Background: Inhibition of mTOR, a downstream mediator of the PI3K/AKT signaling pathway, is a significant anti-cancer approach in response to PI3K/AKT activation, as demonstrated clinically w...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
